WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Earnings & Revenue

TBPH past revenue growth

How has TBPH's revenue growth performed historically?
Company
11.84%
Industry
169.3%
Market
17.86%
TBPH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TBPH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TBPH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TBPH earnings and revenue history

Current Revenue
$57.4M
Current Earnings
-$55.2M
Current Profit Margin
-96.1%

TBPH Return on Equity

Current Company
-19.9%
Current Industry
-63.4%
Current Market
188%
TBPH's Return on Equity (-19.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TBPH announces earnings.

TBPH Return on Assets

Current Company
-12.4%
Current Industry
3.2%
TBPH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TBPH Return on Capital Employed

Current Company
-13.13%
Current Industry
19.9%
TBPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TBPH vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TBPH$57.42M-$40.77M-$55.19M-1.00%N/A
JSPR$0.00-$62.94M-$64.47MN/AN/A
RVNC$234.04M-$290.64M-$323.99M+128.84%N/A
OCS$1.00M-$98.97M-$100.91M-1.76%N/A
IVVD$0.00-$167.85M-$169.56MN/AN/A

TBPH earnings dates

Next earnings date
May 6, 2024

Theravance Biopharma Earnings & Revenue FAQ

What were TBPH's earnings last quarter?

On Invalid Date, Theravance Biopharma (NASDAQ: TBPH) reported Q4 2023 earnings per share (EPS) of -$0.19, up 200% year over year. Total Theravance Biopharma earnings for the quarter were -$8.51 million. In the same quarter last year, Theravance Biopharma's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.

What was TBPH's earnings growth in the past year?

As of Q1 2024, Theravance Biopharma's earnings has grown year over year. Theravance Biopharma's earnings in the past year totalled -$55.19 million.

What is TBPH's earnings date?

Theravance Biopharma's earnings date is Invalid Date. Add TBPH to your watchlist to be reminded of TBPH's next earnings announcement.

What was TBPH's revenue last quarter?

On Invalid Date, Theravance Biopharma (NASDAQ: TBPH) reported Q4 2023 revenue of $17.57 million up 19.91% year over year. In the same quarter last year, Theravance Biopharma's revenue was $14.65 million.

What was TBPH's revenue growth in the past year?

As of Q1 2024, Theravance Biopharma's revenue has grown 11.84% year over year. This is 157.46 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Theravance Biopharma's revenue in the past year totalled $57.42 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.